ARIDHIA INFORMATICS LIMITED

Their core work

Aridhia Informatics is a Glasgow-based health data technology company that builds and operates secure cloud-based analytics platforms for multi-center clinical and biomedical research. They provide the data infrastructure that allows research consortia — typically led by universities or hospitals — to access, analyze, and share sensitive health data in compliant environments. In EU projects, their role is not primary research but rather enabling research at scale: they bring ready-made platform technology so scientists can focus on science rather than data plumbing. Their two H2020 projects show them contributing informatics capability first to oral health clinical research, then to a European-wide platform for neurodegenerative disease biomarkers.

What they specialise in

How they've shifted over time

In their first H2020 project, ADVOCATE (2015-2019), Aridhia contributed to oral care clinical research — a broad health informatics role with no specific technical keywords captured in the data. By their second project, EPND (2021-2026), their focus had sharpened considerably: the project centers on a European-scale data platform for neurodegenerative disorders, with explicit work on biomarkers for Alzheimer's and Parkinson's diseases. This suggests a deliberate move from generalist health data support toward specialized neurological disease data infrastructure, likely tracking demand from the EU's growing investment in brain health research.

Aridhia is positioning itself as a dedicated data platform provider for neurodegenerative disease research, a fast-growing EU priority — making them a likely target partner for future Alzheimer's, Parkinson's, or dementia-related consortia needing compliant data infrastructure.

How they like to work

Aridhia has never coordinated an H2020 project, always joining as a participant — consistent with a technology company that brings a proprietary platform rather than driving the scientific agenda. Despite only two projects, they have connected with 41 unique partners, meaning they operate inside large, complex consortia where their platform is a shared resource for many research teams. This profile suggests they are easy to absorb into a consortium without territorial friction, but they will not take the lead on grant writing or project management.

Aridhia has built connections with 41 unique partners across 16 countries from just two projects, indicating they participate in large, well-networked European RIA consortia rather than small bilateral collaborations. Their geographic spread is broad and Europe-wide, with no visible national clustering.

What sets them apart

Aridhia occupies a specialist niche that most academic health research consortia cannot fill themselves: a compliance-grade, cloud-based data workspace designed for sensitive clinical and biomarker data. As a UK-based SME post-Brexit, they are a rare case of a non-EU partner still actively participating in Horizon Europe projects, which signals strong demand for their specific platform capabilities. For consortium builders in the neurodegenerative disease or precision medicine space, Aridhia offers working infrastructure on day one — no need to budget for building a data platform from scratch.

Highlights from their portfolio

• EPND
  A pan-European biomarker data platform for Alzheimer's and Parkinson's (2021-2026), representing Aridhia's clearest alignment with EU brain health priorities and their most technically specific role to date.
• ADVOCATE
  Aridhia's first and largest-funded H2020 project (EUR 343,356), establishing their EU research credentials across a 2015-2019 clinical oral care consortium.